The role of cardiac myosin-binding protein C (cMyBP-C) in cardiac contraction is still not fully resolved. Experimental ablation of cMyBP-C by various means resulted in inconsistent changes in Ca 2ϩ sensitivity and increased velocity of force of skinned preparations. To evaluate how these effects are integrated in an intact, living myocyte context, we investigated consequences of cMyBP-C ablation in ventricular myocytes and left atria from cMyBP-C knock-out (KO) mice compared with wild-type (WT). At 6 weeks, KO myocytes exhibited mild hypertrophy that became more pronounced by 30 weeks. Isolated cells from KO exhibited markedly lower diastolic sarcomere length (SL) without change in diastolic Ca 2ϩ . The lower SL in KO was partly abolished by the actin-myosin ATPase inhibitors 2,3-butanedione monoxime or blebbistatin, indicating residual actin-myosin interaction in diastole. The relationship between cytosolic Ca 2ϩ and SL showed that KO cells started to contract at lower Ca 2ϩ without reaching a higher maximum, yielding a smaller area of the phase-plane diagram. Both sarcomere shortening and Ca 2ϩ transient were prolonged in KO. Isolated KO left atria exhibited a marked increase in sensitivity to external Ca 2ϩ and, in contrast to WT, continued to develop twitch force at low micromolar Ca 2ϩ . Taken together, the main consequence of cMyBP-C ablation was a defect in diastolic relaxation and a smaller dynamic range of cell shortening, both of which likely result from the increased myofilament Ca 2ϩ sensitivity. Our findings indicate that cMyBP-C functions as a restraint on myosin-actin interaction at low Ca 2ϩ and short SL to allow complete relaxation during diastole. (Circ Res.  2007;101:928-938.) 
C ardiac myosin-binding protein C (cMyBP-C) is located in the A-band of the cardiac sarcomere, where it interacts with myosin, actin, and titin. [1] [2] [3] [4] [5] It consists of 11 modules labeled C0 to C10 from the N to the C terminus. It is assumed to play important structural and functional roles in health and disease (for reviews, see 6 -10 ). Interest in cMyBP-C has intensified since the discovery that mutations in the human gene are frequently involved in familial hypertrophic cardiomyopathy (FHC). [11] [12] [13] [14] Most of them should produce C-terminal truncated cMyBP-Cs 14, 15 that are unstable in cardiac myocytes and undetectable in myocardial tissue of patients. 16 -18 A recent study suggests that they are rapidly and quantitatively degraded by the ubiquitin-proteasome system. 19 cMyBP-C can be phosphorylated at 3 different sites by cAMP-regulated protein kinase and a Ca 2ϩ -calmodulin kinase bound to the thick filament (for reviews, see 6 -10 ). Lower amount of phosphorylated cMyBP-C has been found in human failing heart and atrial fibrillation, 20, 21 and during low-flow ischemia. 22 Recent data suggest that cMyBP-C phosphorylation is cardioprotective. 23 The regulatory role of cMyBP-C on contraction is still controversial, although there is a general agreement that cMyBP-C acts as an internal load. Removal of cMyBP-C can increase the velocity of shortening, force output, and force redevelopment in skinned preparations. 5,24 -27 Addition of N-terminal fragments of cMyBP-C in skinned myocytes activated force production in the absence of Ca 2ϩ . 28 In 2 different cMyBP-C knock-out (KO) mice, fractional shortening was reduced, 29, 30 whereas no change in dP/dt max was found. 30 The maximum Ca 2ϩ -activated force (F max ) was unaltered in skinned myocytes partially depleted in cMyBP-C 24 or isolated from KO mice. 29, 31 The results of ablation or partial extraction of cMyBP-C on Ca 2ϩ sensitivity of skinned myocytes or cardiac preparations varied among different studies. 29, [31] [32] [33] [34] The aim of the present study was to evaluate how these alterations are integrated in an intact, living myocyte context, in which at least some of the compensatory changes for the absence of cMyBP-C remain and can be quantified. For this purpose, we have used intact, freely-suspended adult ventricular myocytes isolated from cMyBP-C WT and KO mice. 30 Both sarcomere shortening and Ca 2ϩ transients were measured. In addition, the relationship between external Ca 2ϩ and force was measured in intact loaded left atrial muscles. The amounts of major myofilament and Ca 2ϩ -handling proteins were determined to detect potential compensatory changes.
Materials and Methods
For an extended description see supplement data (available online at http://circres.ahajournals.org).
Animals
The cMyBP-C KO mice were generated in a blackswiss background as previously described. 30 
Sarcomere Shortening and Ca 2؉ Transients Measurements in Intact Ventricular Myocytes
Ventricular myocytes were isolated from KO and WT hearts as previously described. 20 Cells were incubated in the IonOptix solution (in mmol/L: 135 NaCl, 4.7 KCl, 0.6 KH 2 PO 4 , 0.6 Na 2 HPO 4 , 1.2 MgSO 4 , 1.25 CaCl 2 , 20 glucose, 10 Hepes, pH 7.46) containing 1 mol/L Fura-2-AM for 20 minutes. Sarcomere shortening and Ca 2ϩ transients of intact myocytes were simultaneously assessed on field stimulation (1 Hz with 4 ms duration, 10 V) using a video-based sarcomere length (SL) detection system (IonOptix Corporation) at room temperature. Cells were alternatively excited at 340 and 380 nm with 510 nm emissions using the hyper-switch dual excitation light source. The F340/F380 ratio was used as an index of cytosolic Ca 2ϩ concentration.
Response of Isolated Left Atrial Muscles to External Ca 2؉ , Determination of Myosin-Heavy Chain Content, Western Blot, and Immunofluorescence Analyses
Methods are detailed in the online data supplement.
Results

Contribution of Myocyte Hypertrophy to Ventricular Hypertrophy in cMyBP-C KO Mice
The absence of cMyBP-C in KO mice was verified by immunofluorescence in isolated myocytes ( Figure 1A ). Ven- tricular-to-body-weight ratio was 29% and 44% greater in KO than in WT at 6 and 30 weeks, respectively ( Figure 1B ). Cell length and width of ventricular myocytes were measured in the presence of 10 mmol/L 2,3-butanedione monoxime (BDM). KO myocytes were 18% and 13% longer than WT myocytes at 6 and 30 weeks, respectively, and wider only at 30 weeks by 22% ( Figure 1C ). Cell area, calculated as cell lengthϫwidth, was significantly greater at 6 and 30 weeks (ϩ13% and ϩ28%, respectively), indicating that ventricular hypertrophy in the KO mice was mainly the result of myocyte hypertrophy.
Impairment of Shortening Kinetics in cMyBP-C KO Myocytes
Sarcomere shortenings of intact WT and KO myocytes were measured in 6-week-old (mild hypertrophy) and 30-week-old (larger degree of hypertrophy) mice ( Figure 1D ; Table) . Diastolic SL was markedly lower in KO than in WT myocytes at both ages. In fact, SL in KO in diastole was identical to SL in WT in systole, ie, sarcomere shortening in KO started where it ended in WT. Whereas maximal sarcomere shortening did not change between KO and WT, the kinetics of both sarcomere shortening and relengthening were slower in KO. This worsened with age. Thus, shortening velocity in KO was 34% and 56% lower and relengthening velocity 33% and 49% lower at 6 and 30 weeks, respectively. Interestingly, whereas no correlation was found between diastolic SL and sarcomere shortening in WT (Figure 2A ), a slight, significant negative correlation was found in KO. Systolic SL showed the expected negative correlation with sarcomere shortening in both groups at both ages ( Figure 2B ). However, the slopes were significantly lower in KO and lower with age in both groups. A similar negative correlation was found between systolic SL and relengthening velocity with even more pronounced difference in slope between KO and WT ( Figure 2C ).
Compensatory Changes in cMyBP-C KO Mice
The amount of key myofilament and Ca 2ϩ -handling proteins was determined to investigate potential adaptations to the ablation of cMyBP-C. MHC isoforms were analyzed by long electrophoresis in a polyacrylamide gel containing glycerol ( Figure 3A) . A significant shift from ␣to ␤-MHC was observed in KO at 6 weeks and to a lesser extent at 30 weeks. Thus, the amount of ␤-MHC was 5-fold and 3-fold higher in KO than in WT at 6 and 30 weeks, respectively. This finding was confirmed by Western blot with a ␤-MHC-specific antibody ( Figure 3B ). The amount of sarcoplasmic reticulum Ca 2ϩ -ATPase (SERCA2) and phospholamban (PLB) was identical in KO and WT. However, the level of both phosphorylated forms of PLB was 2-to 3-fold higher in KO than in WT at 30 weeks, but not at 6 weeks of age ( Figure 3B ). Interestingly, the amount of Na ϩ /Ca 2ϩ exchanger (NCX) was 34% lower in KO than in WT ( Figure 3C ).
Residual Diastolic Actin-Myosin Interaction in cMyBP-C KO Myocytes
To test whether lower diastolic SL is explained by active cross-bridge cycling in KO, the effect of 10 mmol/L BDM, a chemical phosphatase that inhibits cross-bridge cycling, 35 in the presence of low external Ca 2 ϩ (0.0125 mmol/L) was examined. Whereas BDM did not change diastolic SL in WT, it increased it by 4.7% in KO ( Figure 4A ). We then investigated whether the BDM effect is also observed in the complete absence of extracellular Ca 2ϩ by adding 1 or 10 mmol/L EGTA. Lowering external Ca 2ϩ from 1.25 to 0.0125 mmol/L induced cell arrest, but did not change diastolic SL in both groups ( Figure 4B and 4C). Of note, cell arrest developed 2-fold slower in KO ( Figure 4B and 4D). EGTA 10 mmol/L did not change diastolic SL in both groups. Whereas BDM did not significantly change diastolic SL in WT, it significantly increased it in KO ( Figure 4C ). Time from BDM injection to plateau tended to be longer in KO (521Ϯ66 versus 380Ϯ54 s in WT, PϾ0.05). Whereas 10 or 30 mmol/L BDM did not fully relax KO cells, 100 mmol/L BDM returned the diastolic SL in KO to WT baseline value (supplemental Figure I) . Similar effects were obtained in KO with 10 mol/L blebbistatin, another inhibitor of actin-activated myosin ATPase 36 (1.73Ϯ0.02 versus 1.69Ϯ0.03 m in EGTA, nϭ4).
Alteration of Ca 2؉ Transient Kinetics but Not Diastolic Ca 2؉ in cMyBP-C KO Myocytes
We then investigated whether lower diastolic SL and slower sarcomere shortening in KO are associated with changes in diastolic Ca 2ϩ and Ca 2ϩ transient kinetics, respectively. Sarcomere shortenings and Ca 2ϩ transients were simultaneously measured in Fura-2-AM-preincubated cells from 6-week-old mice. Diastolic Ca 2ϩ was unaltered in KO ( Figure 5A through 5C). Whereas the increase in time-to-peak shortening was approximately matched by a similar increase in time-to-peak Ca 2ϩ (ϩ27%), the slowing in relengthening (ϩ34%) corresponded to only a minor increase in time-to-50% Ca 2ϩ decay (ϩ11%). In contrast, no alteration of the maximal amplitude of both sarcomere shortening and Ca 2ϩ transients was detected in KO ( Figure 5A through 5C). We therefore evaluated whether varying external Ca 2ϩ concentration reveals defects in KO. Increasing Ca 2ϩ from 0.25 to 2 mmol/L increased the amplitude of Ca 2ϩ transient similarly in both groups, but increased fractional shortening to a slightly lower extent in KO (supplemental Figure IIA) . In contrast, KO cells, which were not preincubated with Fura-2 exhibited a higher sarcomere shortening at 0.5 mmol/L external Ca 2ϩ compared with WT (supplemental Figure IIB) . This divergence may relate to the 4-fold lower sarcomere shortening at 0.5 mmol/L external Ca 2ϩ in the presence of Fura-2 (Ͻ0.9% versus Ͼ3.7% without Fura-2), suggesting that, under our conditions, Fura-2 acted as a Ca 2ϩ buffer masking differences in response to low external Ca 2ϩ .
Altered Relation Between Sarcomere Length and Cytosolic Ca 2؉ in Intact KO Myocytes
To get a more detailed view of the relation between sarcomere shortening and cytosolic Ca 2ϩ we assessed the phaseplane diagrams as previously described for rat myocytes. 37 This analysis revealed a counter-clockwise loop (shortening proceeded upwards), which showed 3 abnormalities in KO ( Figure 5D through 5F): a shift to lower SL, a start of sarcomere shortening at lower Ca 2ϩ , and a smaller area of the loop. Whereas the shift to lower SL recapitulates the effect of alkalosis or pharmacological Ca 2ϩ sensitization, 37, 38 no increase in maximal shortening or leftward shift of the relengthening phase was observed in KO. 
Altered Response of Isolated KO Left Atria to External Ca 2؉
To investigate whether the changes in KO myocyte shortening translate into altered contraction of intact loaded muscle preparations, isolated, electrically paced (1 Hz) left atria were challenged with different external Ca 2ϩ concentrations (Figure 6A and 6B) . When a Ca 2ϩ -free Tyrode's solution was applied (calculated external Ca 2ϩ 0.002 mmol/L), active twitch force quickly ceased in WT, but continued at a reduced steady state for Ͼ5 minutes in KO. Stepwise increases in external Ca 2ϩ concentrations reactivated twitch force in WT and revealed a significantly increased sensitivity to external Ca 2ϩ in KO (EC 50 1.21Ϯ0.17 versus 2.55Ϯ0.19 mmol/L in WT, PϽ0.01). Moreover, cMyBP-C ablation was also associated with a trend toward a reduced slope of the external Ca 2ϩ -force relationship as indicated by a slight, not significant decrease in the Hill coefficient (2.9Ϯ0.7 versus 3.7Ϯ0.8 in WT, nϭ4, PϾ0.05). These data indicate that, under physiological concentrations of external Ca 2ϩ , KO myocytes contract at more than half-maximal force.
Discussion
The precise role of cMyBP-C remains incompletely understood, but the prevailing evidence suggests that it acts as an internal load on actin-myosin interactions. The present data support this interpretation by showing that cMyBP-C abrogation is associated with a marked decrease in diastolic SL in unloaded myocytes and a pronounced increase in the sensitivity to external Ca 2ϩ in isometrically contracting atria. The fact that these changes were already seen in young age and did not go along with changes in intracellular diastolic Ca 2ϩ concentrations support the notion that they are primary consequences of cMyBP-C ablation.
The decrease in diastolic SL in KO from Ϸ1.8 m to Ϸ1.7 m could be the consequence of a reduction in forces restoring SL or an increase in forces shortening SL against the restoring force, ie, increased cross-bridge cycling. The latter is more likely for several reasons. First, in skinned KO myocytes passive tension and its regulation by PKA were unchanged. 31 This argues against relevant changes in titin, which is also the major component of restoring forces in cardiac myocytes. Second, the difference in SL between KO and WT was sensitive to inhibitors of myosin ATPase (BDM or blebbistatin). This indicates that the diastolic SL in KO is, at least to an important part, attributable to residual crossbridge cycling. A similar conclusion was recently drawn in a study evaluating the consequences of a troponin I mutation associated with restrictive cardiomyopathy. 39 Finally, the former evidence that cMyBP-C acts as an internal load on contraction 24 -27 also supports the notion that the reduced resting SL in the absence of cMyBP-C is attributable to the removal of a restraint.
Residual crossbridge cycling in diastole in myocytes lacking cMyBP-C in the absence of an increase in diastolic Ca 2ϩ could either indicate a Ca 2ϩ -independent mechanism 39 or be the consequence of the increased myofilament Ca 2ϩ sensitivity or both. Several arguments favor the second hypothesis. First, a decreased diastolic cell-length has been observed with alkalosis or pharmacological Ca 2ϩ sensitizers. 37, 38 Second, the phase-plane diagrams revealed that KO myocytes started to shorten at lower cytosolic Ca 2ϩ than WT. Third, loaded KO left atria still exhibited active twitch force in nominally 0.002 mmol/L external Ca 2ϩ whereas WT did not, and the EC 50 for external Ca 2ϩ to stimulate force was more than 2-fold lower than in WT. Preliminary results indicate that the amplitude of L-type Ca 2ϩ current was similar in KO and WT myocytes suggesting that the higher sensitivity of KO atria to external Ca 2ϩ is independent of increased Ca 2ϩ influx (L. Pohlmann, M. Kruse, O. Pongs, E. Eschenhagen, L. Carrier, unpublished data, 2007) . However, in contrast to classical Ca 2ϩ sensitization, no increase in maximal shortening or leftward shift of the relengthening phase was observed in KO ( Figure 5 ). These data suggest that the ablation of cMyBP-C promotes myofilament Ca 2ϩ response predominantly at low, diastolic Ca 2ϩ , without effect at high Ca 2ϩ .
This interpretation is well compatible with 2 recent studies on skinned myocyte Ca 2ϩ sensitivity. Whereas earlier studies had reported mixed effects of extraction or ablation of cMyBP-C on Ca 2ϩ sensitivity in skinned preparations (increase, 31, 32 no change, 40 or decrease 25, 29 ), the newer data on skinned KO preparations demonstrated a lower Hill coefficient of the pCa-force relation, indicating a reduced cooperativity of the myofilament activation. 27, 31 A potential mechanistic explanation for this finding comes from a recent study describing a radial displacement of cross-bridges away from the thick filament in the absence of Ca 2ϩ . 41 These results are consistent with a model in which cMyBP-C normally acts to tether myosin cross-bridges nearer to the thick filament backbone, thereby reducing the likelihood of cross-bridge binding to actin under low Ca 2ϩ concentrations.
The present results were obtained in a KO model, in which, in contrast to another model, 29 the transcription start site of the cMyBP-C gene was eliminated. 30 This strategy results in a complete lack of both cMyBP-C mRNA and protein, but does not exclude that our results are influenced by compensatory mechanisms. Indeed, several observations favor this notion. KO exhibited cardiac hypertrophy and a fetal gene expression program ( 30 and present study), hyperphosphorylation of PLB at older age and downregulation of NCX. One may speculate that the higher amount of the slow ␤-MHC partially compensates for the increased propensity of actinmyosin interaction in cMyBP-C KO, and it is likely that it contributes to the slower sarcomere shortening in KO. 42, 43 However, whereas myocyte dysfunction worsened in KO with age the ␤-MHC fraction decreased more than 2-fold. This argues against the idea that upregulation of ␤-MHC is a major cause of myocyte dysfunction in KO. Similarly, the markedly slower relaxation and Ca 2ϩ transient decay observed in KO cells was not associated with and can therefore not be explained by a change in the amount of SERCA2 or PLB. In contrast, the higher level of both phosphorylated forms of PLB in 30-week-old KO mice suggests that the mice partially compensate the intrinsic relaxation deficit by activating a pathway that accelerates Ca 2ϩ uptake into the SR and therefore hastens relaxation. Preliminary results indicate a higher density of the ␤-receptors in myocardium and a stronger inotropic effect of isoprenaline in myocytes from KO mice, and therefore support this interpretation (L. Pohl- (Figures 4 and 6 ). This observation points to a defect of KO to extrude Ca 2ϩ and is likely related to the decreased levels of NCX ( Figure 3C) , to the higher Ca 2ϩ sensitivity of the myofilaments that may retain Ca 2ϩ , 39, 44 or both. In any case, both alterations likely contribute to the slower sarcomere relengthening and Ca 2ϩ decay in KO. It is difficult to decide to which extent the lack of cMyBP-C as such participates in the altered kinetics of shortening, but the significantly lower slope of the correlation between systolic SL and relengthening velocity in KO (Figure 2C) suggests that the absence of cMyBP-C also affects the onset and/or the velocity of relaxation. This is compatible with an inhibitory effect of cMyBP-C on cross-bridge cycling and increased Ca 2ϩ sensitivity in KO.
Residual cross-bridge cycling in diastole, incomplete relaxation, and increased Ca 2ϩ -sensitivity of the myofilaments are expected to translate into diastolic dysfunction, basal hypercontractility, and increased energy expenditure, all of which are typical features of FHC. [45] [46] [47] Indeed, the hemodynamic measurements in the same KO mice have revealed decreased dP/dt min and increased Tau, as well as an increased LV end-systolic meridional wall stress in the basal state. 30 On the other hand, cMyBP-C ablation was associated with a reduced absolute response to increasing external Ca 2ϩ (from 1.8 to 6.4 mmol/L) in intact atria ( Figure 6 ), a reduced length-dependent activation in skinned myocytes, 31 and a blunted response to dobutamine in vivo. 30 Taken together, these data indicate that the physiological role of cMyBP-C is to increase the dynamic range of myofilament responses mainly by allowing complete relaxation under diastolic conditions. A problem with this model is that, as recently pointed out by de Tombe, 8 the substantial contractile activation in diastole should be incompatible with life. Whereas this is obviously not the case in mice, the same does not necessarily apply to human in which cardiac function depends much more on regulation of contractile force. Indeed, a homozygous Q76ter mutation, which is expected to produce a functional cMyBP-C KO, has been shown to be associated with massive hypertrophy and sudden death by 9 months of age in a FHC patient. 14 Taken together, our results suggest that cMyBP-C acts as an internal load that tethers myosin heads to the thickfilament backbone and prevents force generation in diastole. Its absence causes cross-bridge cycling at low diastolic Ca 2ϩ , higher myofilament Ca 2ϩ sensitivity with a reduced cooperativity, hypercontractility in the basal state, and reduced dynamic range of contraction. These changes are well compatible with the phenotype of human FHC and, in human, are likely to occur even when the amount of cMyBP-C is discretely reduced as may result from haploinsufficiency. 
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